Naproxen Orion (Naproxen)

Naproxen works by non‑selectively blocking the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and fever generation.

The appropriate dose of Naproxen Orion is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and overall health status. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety of naproxen during pregnancy or lactation depends on the trimester and individual risk factors. It is generally advised to consult a qualified healthcare provider before using Naproxen Orion while pregnant or breastfeeding to weigh potential benefits against risks.

To order Naproxen Orion, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a quicker onset. Choice between them depends on clinical judgment, patient tolerance, and specific therapeutic goals.

Naproxen Orion should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture, direct sunlight and excessive heat to maintain stability and potency throughout its shelf life.

Naproxen Orion is taken orally, usually with a full glass of water. It can be taken with or without food, although taking it with food may reduce gastrointestinal discomfort. Patients should swallow the tablet whole and not crush or chew it unless directed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, renal impairment, severe skin reactions, and hepatic dysfunction. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Naproxen Orion should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, active gastrointestinal ulceration or bleeding, severe heart failure, uncontrolled hypertension, and in patients who are in the third trimester of pregnancy unless specifically advised by a physician.